ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2026

Abstract Number: 0008

Transcriptome analysis of temporal artery and aortic lesions highlights vessel-specific chemotaxis and cell adhesion in GCA

Ingrid Lindquist1, Cong-Qiu Chu2, Kimberly Winges3, James Rosenbaum4, David Daikh5 and Marcia Friedman6

Affiliations: 1Portland VA Medical Center, Oregon Health & Science University, Portland, OR, 2Oregon Health & Science University, Portland, OR, 3Portland VA Medical Center, Portland, OR, 4Legacy Devers Eye Institute, Portland, OR, 5Oregon Health and Science University and Portland VAMC, Portland, OR, 6Amgen, Beaverton, OR

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2026

Keywords: Adhesion, Adhesion molecules, chemokines, Gene Expression, giant cell arteritis

Session Information

Date: Sunday, November 8, 2026

Title: (0001-0008) Vasculitis - Basic and Translational Science Poster A

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Background: Giant cell arteritis (GCA) is an inflammatory vasculitis of medium and large arteries with a spectrum of phenotypes. Cranial-GCA is associated with blindness and positive temporal artery (TA) biopsies, while large-vessel GCA more often presents with PMR and aortic complications. The basis for differing vessel involvement is unknown. Histopathology shows T-cell-dominant infiltrates in TAs, while more B-cells and developed artery tertiary lymphoid organs (ATLOs) are found in aortas. We hypothesize that gene expression differences, particularly in pathways of cell recruitment and adhesion, may underlie these patterns.

Methods: Methods: Three transcriptome analyses were completed: (1) TA biopsies from biopsy-positive GCA (n=21) versus controls (n=30), RNAseq; (2) aortic tissue from GCA (n=19) versus atherosclerotic controls (n=19), RNAseq (GSE224526); (3) pulmonary vascular bed biopsy in another disease with classic granulomatous inflammation, sarcoid (n=6) versus controls (n=6) , microarray (GSE16538). Differential expression (DE) was assessed with DESeq2 or GEO2R. Pathways of chemokines, cell adhesion molecules (CAM), and fibrosis-related genes (FRG) were obtained from Reactome and FibROAD.

Results: Results: DE genes included 2,261 in GCA-TA, 9,078 in GCA-aorta, and 1,142 in sarcoid. The 135 genes shared across all most likely reflect non-specific granulomatous inflammation. Genes (1,777) significant in both GCA-TA and GCA-aorta but not sarcoid included 35 CAM, 9 chemokines, and 48 FRG. TA-specific genes (342) included 5 CAM, 4 chemokines, and 13 FRG; CCL22 was most upregulated (log2FC4.0) of these chemokines and is known to recruit activated t-lymphocytes, a hallmark of TA lesions. Pathway enrichment analysis found cell adhesion and chemotaxis processes in four of top ten categories (Figure 1). Aorta-specific genes (6,714) included 40 CAM, 13 chemokines, and 85 FRG; CXCL13 was most upregulated (log2FC4.4),and has been reported elevated in circulating B cells in GCA-PMR. CXCL13 may be an integral agent in ALTOs in aortic lesions.

Conclusion: Conclusions: This integrated transcriptome-wide analysis in TA and aortic tissues in GCA highlights vessel-specific chemotaxis, advancing understanding of vascular involvement and informing biomarker and therapeutic development.

Supporting image 1Figure 1. Pathway enrichment (biological process) analysis from 342 genes significantly differentially expressed only in temporal artery tissue in GCA vs control. Four of these top 10 belong to chemotaxis and cell adhesion.


Disclosures: I. Lindquist: None; C. Chu: Sobi, 12,; K. Winges: None; J. Rosenbaum: American College of rheumatology, 12,, Corvus, 12,, Corvus Pharmaceuticals, 12,, Priovant Therapeutics, 12,, Roche, 12,, 12, ; D. Daikh: None; M. Friedman: Alpine immune sciences, a vertex company, 12,, 12, , Amgen, 12,, 12, , Lyell immunopharma, 12,, 12, .

To cite this abstract in AMA style:

Lindquist I, Chu C, Winges K, Rosenbaum J, Daikh D, Friedman M. Transcriptome analysis of temporal artery and aortic lesions highlights vessel-specific chemotaxis and cell adhesion in GCA [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 9). https://acrabstracts.org/abstract/transcriptome-analysis-of-temporal-artery-and-aortic-lesions-highlights-vessel-specific-chemotaxis-and-cell-adhesion-in-gca/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/transcriptome-analysis-of-temporal-artery-and-aortic-lesions-highlights-vessel-specific-chemotaxis-and-cell-adhesion-in-gca/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology